About this medicine
- Approved name
- APPM Respipharm
- International non-proprietary name (INN) or common name
- formaldehyde-inactivated whole-cell bacterial vaccine containing three strains of Actinobacillus pleuropneumoniae (serotypes 2, 9 and 11) and one strain of Pasteurella multocida (serotype A)
About this procedure
- Current status
- European Commission final decision
- Reference number
- EMA/839689/2009
- Type
- Article 33
Mutual-recognition and decentralised referral: initiated because of disagreement between Member States within the framework of the mutual-recognition or decentralised procedure.
Key dates and outcomes
- Opinion date
- 11/11/2009
- EC decision date
- 27/01/2010